Søren Brøgger Christensen

About Søren Brøgger Christensen

Søren Brøgger Christensen, With an exceptional h-index of 63 and a recent h-index of 33 (since 2020), a distinguished researcher at Københavns Universitet, specializes in the field of thapsigargin, SERCA, mipsagargin.

His recent articles reflect a diverse array of research interests and contributions to the field:

Development of β-lactams since 1986. Commentary on The discovery of penicillin and cephalosporins by Sydney Selwyn

Validation of anti-malarial leads from natural products and traditional medicine for treatment of malaria

Drugs that changed society: microtubule-targeting agents belonging to taxanoids, macrolides and non-ribosomal peptides

Natural Products That Changed Society. Biomedicines 2021, 9, 472

From plant to patient: thapsigargin, a tool for understanding natural product chemistry, total syntheses, biosynthesis, taxonomy, ATPases, cell death, and drug development

Mipsagargin: The beginning—Not the end—Of thapsigargin prodrug-based cancer therapeutics

Drugs that changed society: History and current status of the early antibiotics: Salvarsan, sulfonamides, and β-lactams

Natural products that changed society

Søren Brøgger Christensen Information

University

Position

___

Citations(all)

13762

Citations(since 2020)

3578

Cited By

10636

hIndex(all)

63

hIndex(since 2020)

33

i10Index(all)

166

i10Index(since 2020)

83

Email

University Profile Page

Google Scholar

Søren Brøgger Christensen Skills & Research Interests

thapsigargin

SERCA

mipsagargin

Top articles of Søren Brøgger Christensen

Title

Journal

Author(s)

Publication Date

Development of β-lactams since 1986. Commentary on The discovery of penicillin and cephalosporins by Sydney Selwyn

Søren Brøgger Christensen

2024/1/1

Validation of anti-malarial leads from natural products and traditional medicine for treatment of malaria

Søren Brøgger Christensen

2022/1/1

Drugs that changed society: microtubule-targeting agents belonging to taxanoids, macrolides and non-ribosomal peptides

Søren Brøgger Christensen

2022/9/1

Natural Products That Changed Society. Biomedicines 2021, 9, 472

Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development

SB Christensen

2021

From plant to patient: thapsigargin, a tool for understanding natural product chemistry, total syntheses, biosynthesis, taxonomy, ATPases, cell death, and drug development

Søren Brøgger Christensen

Henrik Toft Simonsen

Nikolai Engedal

Poul Nissen

Jesper Vuust Møller

...

2021

Mipsagargin: The beginning—Not the end—Of thapsigargin prodrug-based cancer therapeutics

John T Isaacs

William Nathaniel Brennen

Søren Brøgger Christensen

Samuel R Denmeade

2021/12/9

Drugs that changed society: History and current status of the early antibiotics: Salvarsan, sulfonamides, and β-lactams

Søren Brøgger Christensen

2021/10/7

Natural products that changed society

Søren Brøgger Christensen

2021/4/26

Targeting toxins toward tumors

Henrik Franzyk

Søren Brøgger Christensen

2021/2/27

Large Scale Conversion of Trilobolide into the Payload of Mipsagargin: 8-O-(12-Aminododecanoyl)-8-O-Debutanoylthapsigargin

Biomolecules

Tomáš Zimmermann

Pavel Drašar

Silvie Rimpelová

Søren Brøgger Christensen

Vladimir A Khripach

...

2020/12/5

Cell death induced by the ER stressor thapsigargin involves death receptor 5, a non-autophagic function of MAP1LC3B, and distinct contributions from unfolded protein response …

Cell Communication and Signaling

Paula Lindner

Søren Brøgger Christensen

Poul Nissen

Jesper Vuust Møller

Nikolai Engedal

2020/12

Shedding light on how ER stressors can be used to treat disease

Paula Lindner

Søren Brøgger Christensen

Poul Nissen

Jesper Vuust Møllerd

Nikolai Engedal

2020/10/29

See List of Professors in Søren Brøgger Christensen University(Københavns Universitet)

Co-Authors

academic-engine